MA26510A1 - Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete - Google Patents
Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabeteInfo
- Publication number
- MA26510A1 MA26510A1 MA25121A MA25121A MA26510A1 MA 26510 A1 MA26510 A1 MA 26510A1 MA 25121 A MA25121 A MA 25121A MA 25121 A MA25121 A MA 25121A MA 26510 A1 MA26510 A1 MA 26510A1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical compositions
- treating diabetes
- insulin sensitizer
- antihyperglycemic agent
- antihyperglycemic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26510A1 true MA26510A1 (fr) | 2004-12-20 |
Family
ID=26311746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25121A MA26510A1 (fr) | 1997-06-18 | 1998-06-17 | Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0975343A1 (no) |
JP (1) | JP2001523271A (no) |
KR (1) | KR20010013845A (no) |
CN (1) | CN1274282A (no) |
AP (1) | AP9901720A0 (no) |
AR (2) | AR013352A1 (no) |
AU (1) | AU8799998A (no) |
BG (1) | BG103966A (no) |
BR (1) | BR9810186A (no) |
CA (1) | CA2294134A1 (no) |
CO (1) | CO4940453A1 (no) |
DZ (1) | DZ2519A1 (no) |
EA (1) | EA200000040A1 (no) |
IL (1) | IL133138A0 (no) |
MA (1) | MA26510A1 (no) |
NO (1) | NO996270L (no) |
NZ (1) | NZ501345A (no) |
OA (1) | OA11631A (no) |
PE (1) | PE89199A1 (no) |
PL (1) | PL337577A1 (no) |
SK (1) | SK179499A3 (no) |
TR (1) | TR199903072T2 (no) |
UY (1) | UY25051A1 (no) |
WO (1) | WO1998057635A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000064892A2 (en) | 1999-04-23 | 2000-11-02 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
CA2442917C (en) | 2001-04-04 | 2011-02-01 | Ortho-Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
DE60233655D1 (de) | 2001-04-04 | 2009-10-22 | Ortho Mcneil Janssen Pharm | R und retinoid x rezeptorenmodulatoren |
FR2832930A1 (fr) * | 2001-12-03 | 2003-06-06 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
JP2004067575A (ja) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | 糖尿病治療薬効果促進剤 |
CN101121004B (zh) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | 含有胰岛素增敏剂和米格列醇的药物组合物 |
CN101584688B (zh) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
CN101584705B (zh) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0601001B1 (en) * | 1991-08-26 | 1997-04-16 | PHARMACIA & UPJOHN COMPANY | Liquid food product containing 3-guanidinopropionic acid |
US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 CN CN98806319A patent/CN1274282A/zh active Pending
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/xx unknown
- 1998-06-15 IL IL13313898A patent/IL133138A0/xx unknown
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/pt not_active IP Right Cessation
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Application Discontinuation
- 1998-06-15 JP JP50375699A patent/JP2001523271A/ja not_active Ceased
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/ko not_active Application Discontinuation
- 1998-06-15 SK SK1794-99A patent/SK179499A3/sk unknown
- 1998-06-15 EA EA200000040A patent/EA200000040A1/ru unknown
- 1998-06-15 PL PL98337577A patent/PL337577A1/xx unknown
- 1998-06-17 MA MA25121A patent/MA26510A1/fr unknown
- 1998-06-17 AR ARP980102882A patent/AR013352A1/es unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/xx active
- 1998-06-17 AR ARP980102885A patent/AR014881A1/es unknown
- 1998-06-18 UY UY25051A patent/UY25051A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/es unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/es not_active Application Discontinuation
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/bg unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA200000040A1 (ru) | 2000-08-28 |
CN1274282A (zh) | 2000-11-22 |
JP2001523271A (ja) | 2001-11-20 |
SK179499A3 (en) | 2000-11-07 |
AR013352A1 (es) | 2000-12-27 |
EP0975343A1 (en) | 2000-02-02 |
PL337577A1 (en) | 2000-08-28 |
CO4940453A1 (es) | 2000-07-24 |
AR014881A1 (es) | 2001-04-11 |
NZ501345A (en) | 2001-10-26 |
NO996270D0 (no) | 1999-12-17 |
WO1998057635A1 (en) | 1998-12-23 |
TR199903072T2 (xx) | 2000-07-21 |
KR20010013845A (ko) | 2001-02-26 |
BR9810186A (pt) | 2000-08-08 |
AU8799998A (en) | 1999-01-04 |
CA2294134A1 (en) | 1998-12-23 |
AP9901720A0 (en) | 1999-12-31 |
PE89199A1 (es) | 1999-10-23 |
OA11631A (en) | 2004-11-22 |
NO996270L (no) | 1999-12-17 |
DZ2519A1 (fr) | 2003-02-01 |
IL133138A0 (en) | 2001-03-19 |
UY25051A1 (es) | 2000-09-29 |
BG103966A (bg) | 2000-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2520A1 (fr) | Composition pharmaceutique pour une méthode de traitement du diabète sucré. | |
NO993646D0 (no) | Tiazol benzensulfonamider som <beta>3-agonister for behandling av diabetes og fedme | |
NL300432I2 (en) | Pharmaceutical composition comprising pioglitazoneand glimepiride for use in treatment of diabetes. | |
MA26510A1 (fr) | Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete | |
MX9802130A (es) | Agonistas adrenergicos beta3 selectivos. | |
FR2732223B1 (fr) | Composition pharmaceutique pour administration transdermique | |
DZ2539A1 (fr) | Compositions pharmaceutiques pour le traitement dela résistance à l'insuline. | |
BE881680A (fr) | Composition pharmaceutique a base d'acylcarnitine pour le traitement d'un metabolisme cerebral altere et methode utilisee a cet effet | |
DZ1850A1 (fr) | Formulation nouvelle comprenant un complexe de paroxétine et d'amberlite irp 88. | |
TNSN96072A1 (fr) | N-(indole -2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant | |
FI972287A (fi) | Uudenlaisia polysubstituoituja DTPA-johdoksia ja niiden metallikomplekseja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita, niiden käyttö diagnosoinnissa ja terapiassa sekä menetelmiä kyseisten kompleksinmuodostajien ja kompleksien valmistamiseksi ja menetelmiä kyseisten. | |
TNSN96104A1 (fr) | Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant | |
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
DE69629413D1 (de) | Flüssigkristallverbindung und diese enthaltende Flüssigkristall-Zusammensetzung | |
DZ2521A1 (fr) | Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement. | |
FR2716075B1 (fr) | Procédé pour renforcer l'efficacité d'un produit chimique agricole, renforçateur et composition de renforçateur utilisés dans ce procédé et composition chimique agricole comprenant ce renforçateur. | |
BR0011928A (pt) | Composto, composição farmacêutica, uso de, um composto e métodos para o tratamento de complicações diabéticas, para o tratamento ou a prevenção do desenvolvimento de condições de doença associadas com velocidade de condução neuronial prejudicada e de neuropatia diabética | |
MA24571A1 (fr) | Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitement | |
FR2559668B1 (fr) | Compositions pharmaceutiques pour le traitement du diabete et de maladies et defauts de fonctionnement du foie | |
FR2752422B1 (fr) | Composition pharmaceutique contenant des acides 4-oxo-butanoiques | |
HUP0003626A2 (hu) | Gyógyszerkészítmény diabetes kezelésére dioxo-tiazolidinnel, inzulin secretagogummal és alfa-glükozidáz inhibitorral | |
DZ2564A1 (fr) | Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés. | |
DE69630156D1 (de) | Naphtholverbindung sowie Flüssigkristallzusammensetzung und Flüssigkristallelement, die diese Verbindung enthalten | |
DE69704240D1 (de) | Flüssigentwicklerzusammensetzung und Verfahren zu deren Herstellung | |
FR2718024B1 (fr) | Médicament et composition pharmaceutique pour le traitement de l'inflammation. |